Intravenous Zoledronic Acid Versus Oral Alendronate in the Treatment of Osteoporosis in Older Adults

摘要：

OBJECTIVE: This study aimed to evaluate and compare intravenous zoledronic acid and oral alendronate for the treatment of osteoporosis in the elderly.METHOD: The study was designed to compare a once yearly intravenous dose of zoledronic acid 5 mg with a once weekly oral dose of alendronate 70 mg with respect to markers of serum β-C-terminal telopeptide of type Ⅰ collagen (β-CTX), procollagen type Ⅰ C-terminal propeptide (PICP),N-terminal midfragment of osteocalcin (NMID) and bone mineral density in 90 older patients with osteoporosis in China.

作者: J.J.Jiang Y.M.Yang

作者单位: the First Affiliated Hospital of Medical College, Zhejiang University,Hangzhou, Zhejiang, China

会议类型: 国内会议

会议名称: 2015中国老年医学和老年健康产业大会

会议地点: 苏州

会议语种:英文

页码: 175-175

在线出版日期: 2015-09-11（万方平台首次上网日期，不代表论文的发表时间）